JENNIFER HEISSERER: Open Payments
NPI 1265092134 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 45 payments from 13 companies in 2025. Trend: 2023 $784 · 2024 $1,299 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $200 |
| Merck Sharp & Dohme LLC | 6 | $102 |
| E.R. Squibb & Sons, L.L.C. | 6 | $99 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| PFIZER INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: REPATHA, ELIQUIS, VERQUVO, AMVUTTRA, JARDIANCE, Wegovy, CAMZYOS, LifeVest.
Industry payments across AR — which companies pay providers there.
